A generalized cutaneous reaction induced by granulocyte colony-stimulating factor

Journal of the American Academy of Dermatology

Volumn 34, Issue 3, 1996, Pages 455-459

  Glass, L Frank ^a,b   Fotopoulos, Theodore ^a   Messina, Jane L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b MDC Box 19   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CEFTAZIDIME; CHLORMETHINE; CYTARABINE; FLUDARABINE; FLUOROURACIL; GENTAMICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; METHOTREXATE; METRONIDAZOLE; MITOXANTRONE; OFLOXACIN; PACLITAXEL; PENTAMIDINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; HISTOLOGY; HODGKIN DISEASE; HUMAN; NEUTROPENIA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT OUTCOME;

EID: 0029862717     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90439-9     Document Type: Article

References (20)

1. Wakefield PE, James WD, Samlaska CP, et al. Colony-stimulating factors. J AM ACAD DERMATOL 1990;23:903-12.
2. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors: a review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994;130:77-81.
3. Samlaska CP, Noyes DK. Localized cutaneous reactions to granulocyte colony-stimulating factor [Letter]. Arch Dermatol 1993;129:645-6.
4. Ross HJ, Moy LA, Kaplan R, et al. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991;68:441-3.
5. Paydas S, Sahin B, et al. Sweet's syndrome associated with G-CSF. Br J Haematol 1993;85:191-2.
6. Fukutoku M, Shimizu S, et al. Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia. Br J Haematol 1994; 86:645-8.
7. Park JW, Mehrota B, et al. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med 1992;116:996-8.
8. Jain KK. Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J AM ACAD DERMATOL 1994; 31:213-5.
9. Ostlere LS, Harris D, et al. Widespread folliculitis induced by human granulocyte-colony-stimulating factor therapy [Letter]. Br J Dermatol 1992;127:193-4.
10. Mehregan DR, Fransway AF, et al. Cutaneous reactions to granulocyte-monocyte colony-stimulating factor. Arch Dermatol 1992;128:1055-9.
11. Horn TD, Burke PJ, et al. Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption. Arch Dermatol 1991;127:49-52.
12. Ward JC, Gitlin JB, et al. Epidermolysis bullosa acquisita induced by GMCSF: a role for eosinophils in treatment related toxicity. Br J Haematol 1992;81:27-32.
13. Peters MS, Argenyi Z, et al. Friday evening slide symposium:case 8. J Cutan Pathol 1993;20:465-78.
14. Scott GA. Report of three cases of cutaneous reactions to granulocyte macrophage-colony stimulating factor and a review of the literature. Am J Dermopathol 1995;17:107-14.
15. Ackermann AB. Histologic diagnosis of inflammatory skin diseases. Philadelphia: Lea & Febiger, 1978:196-7.
16. Barker JN, Sarma V, et al. Marked synergism between tumor necrosis factor α and interferon γ in regulation of keratinocyte-derived adhesion molecules and chemotactic factor. J Clin Invest 1990;85:605-8.
17. Dreicer R, Schiller JH, Carbone PP. Granulocyte-macrophage colony stimulating factor and vasculitis. Ann Intern Med 1989;111:91-2.
18. Weite Z, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990;75:1056-63.
19. Wodzinski MA, Hampton KK, Reilly JT. Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia. Br J Haematol 1991;77:249-50.
20. Steger GG, Locker G, et al. Cutaneous reactions to GM-CSF in inflammatory breast cancer [Letter]. N Engl J Med 1992;327:286.